Skip to content Skip to footer
Jivi: Benefits, Reviews, Info, Side Effects!
Rx Details
Jivi
Antihemophilic factor (recombinant), PEGylated-auclotide, BAY 94-9027
Antihemophilic Factor (Recombinant), PEGylated-aucl
Prescription
Medication
Drugs
Prescription Only
longer duration of action, reduced infusion frequency, improved quality of life for hemophilia A patients, potential for fewer bleeding episodes, recombinant factor VIII therapy, suitable for previously treated patients
Back Pain, Cough, Dizziness, Fever, Headache, Itching, Joint Pain, Nausea, Rash, Redness At The Injection Site, Sore Throat, Vomiting
Jivi is a brand name for a recombinant factor VIII product used in the treatment of hemophilia A. The dosage of Jivi is individualized based on the patient’s weight, the severity of the factor VIII deficiency, and the clinical response. Typically, the dosage is calculated in international units (IU) per kilogram of body weight. For routine prophylaxis, the recommended initial regimen is 30-40 IU/kg twice weekly, with adjustments made based on the patient’s bleeding episodes and factor VIII levels. For on-demand treatment of bleeding episodes, the dosage will vary depending on the severity of the bleed and the desired factor VIII level. It’s important to follow the specific dosing instructions provided by a healthcare professional, as they will tailor the treatment to the individual’s needs. Always consult with a healthcare provider for precise dosing information.
Hemophilia a
Jivi has a favorable safety profile.
No interactions found
$5,000 – $10,000
$10,000 for a 4 syringe pack.

A Synopsis of

Jivi

Jivi is a medication that is used to treat and prevent bleeding episodes in individuals with hemophilia A. Hemophilia A is a genetic disorder that affects the blood’s ability to clot properly, leading to prolonged bleeding and difficulty in stopping bleeding after an injury. Jivi works by replacing the missing or deficient factor VIII in the blood, which is necessary for clotting to occur.

This medication is administered through an injection under the skin, typically every few days depending on the individual’s specific needs and treatment plan. It is important to follow the dosing instructions provided by your healthcare provider to ensure the best possible outcomes.

Jivi has been shown to be effective in reducing the frequency of bleeding episodes in individuals with hemophilia A, as well as in preventing bleeding during surgical procedures. It is important to continue taking this medication as prescribed, even if you are not experiencing any bleeding episodes, to maintain adequate levels of factor VIII in the blood.

As with any medication, there may be side effects associated with Jivi. These can include injection site reactions, headaches, and dizziness. It is important to discuss any concerns or side effects with your healthcare provider.

Overall, Jivi is a valuable treatment option for individuals with hemophilia A, helping to improve their quality of life and reduce the risk of bleeding complications. If you have been prescribed Jivi, be sure to follow your healthcare provider’s instructions and reach out with any questions or concerns.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN